NCT04618978

Brief Summary

Periodic Limb Movements during Sleep (PLMs) are episodes of repetitive, stereotypical, hallux or foot movements. They could induce sleep disturbance, fatigue, daytime sleepiness and impaired quality of life but also increased cardiovascular risk by rising heart rate and blood pressure at night. Gold standard for PLMs diagnosis is based on electromyographic recording of tibialis anterior muscle during full night polysomnography (PSG). PLMs prevalence is higher in patients with spinal cord injury (SCI) possibly due to a loss of encephalic inhibition on a spinal motion generator. In these patients, PLMs can also be wrongly considered as spasms sometimes leading to the unjustified implantation of an intrathecal Lioresal pump. In the general population, drug treatments for PLMs, particularly dopamine agonists, limit the impact of these abnormal movements on sleep fragmentation, daytime alertness and quality of life. Underdiagnosed PLMs in SCI patients can lead to exacerbate cognitive, mood and painful disorders due to the close interaction between sleep disorders and neurocognitive, psychological and painful manifestations. PLMs appropriate diagnosis appeared mandatory in those patients but accessibility and delayed availability remain challenging. In addition, sleep laboratories are often unable to accommodate with SCI patients. In this context, actigraphy, an easy-to-use, cheaper and easily renewable diagnostic tool would be interesting. In the general population, sensitivity to diagnose PLMs was between 0.79 and 1 and specificity between 0.6 and 0.83. Due to lower limbs impairment, increased specificity is expected SCI patients (decrease voluntary activity). The new generation of actigraph (MotionWatchR) could have better characteristics thanks to the development of a specific software which integrate both lower limbs in the same analysis. As primary objective, this prospective monocentric study aims to evaluate the performances of lower limbs actigraphy for PLMs diagnosis versus gold standard.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 23, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 6, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

February 25, 2021

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 4, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2025

Completed
Last Updated

February 11, 2025

Status Verified

January 1, 2025

Enrollment Period

3.4 years

First QC Date

October 23, 2020

Last Update Submit

February 10, 2025

Conditions

Keywords

spinal cord injurymultiple sclerosisperiodic leg movementsspasticityperiodic limb movement disorder

Outcome Measures

Primary Outcomes (1)

  • The Receiver Operating Characteristic (ROC) analysis

    Area under ROC curve of the actimeter (indices of periodic movement of legs, defined by the ratio between the number of periodic movement of low limbs during sleeping time and estimated sleeping duration in hour), compared with polysomnography to have diagnosis of periodic movement of legs during sleeping (period of sleeping defined by absence of light and movement of up limb of the more mobile with actimeter).

    Through study completion, an average of 3 years

Secondary Outcomes (8)

  • Predictive values estimation

    Through study completion, an average of 3 years

  • Threshold of PLMs Index

    up to 24 hours

  • Lower limb nocturnal movements evaluation

    up to 24 hours

  • PLMs diagnosis based on the actigraphy

    Through study completion, an average of 3 years

  • Kappa coefficient

    Through study completion, an average of 3 years

  • +3 more secondary outcomes

Study Arms (1)

PSG and actigraphy device evaluations

OTHER

All patients will be evaluated and diagnosed according to the records by Gold standard for PLMs diagnosis and also by the actigraphy devices recording.

Procedure: PSG and actigraphy recording

Interventions

Gold standard: electromyographic recording of tibialis anterior muscle during full night polysomnography (PSG). The new generation actigraphs devices Actiwatch will be combined to PSG as a screening tool: MotionWatch will be placed on the dorsum of feet to record).

PSG and actigraphy device evaluations

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient With Spinal Cord Injury from traumatic or medical aetiology (including patient with multiple sclerosis);
  • Patients with complete or incomplete SCI (AIS-A, B, C, D and E);
  • Neurological level between C4 and L1;
  • Aged \>18 years;
  • Patients with already scheduled full night polysomnography (PSG);
  • Affiliated to social security system;
  • Absence of medical intercurrent event.

You may not qualify if:

  • Specific criteria:
  • History of lower limbs amputation ;
  • Cutaneous lesion compromising actigraphy positioning
  • Presence of spinal cord stimulation equipment, Brindley electrodes, history of spinal cord surgery.
  • No-specific criteria:
  • Patient refusal;
  • Participation in another interventional study involving human participants
  • Unable to sign informed consent form;
  • Emergency condition;
  • Legal protection (i.e. incompetence to provide consent, guardianship, curator or incarceration);
  • No affiliation to a social security system.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physiologie, explorations fonctionnelles - Unité des pathologies du sommeil, Hôpital Raymond Poincaré, APHP

Garches, 92380, France

Location

Related Publications (10)

  • Siddiqui F, Strus J, Ming X, Lee IA, Chokroverty S, Walters AS. Rise of blood pressure with periodic limb movements in sleep and wakefulness. Clin Neurophysiol. 2007 Sep;118(9):1923-30. doi: 10.1016/j.clinph.2007.05.006. Epub 2007 Jun 27.

    PMID: 17588809BACKGROUND
  • Proserpio P, Lanza A, Sambusida K, Fratticci L, Frigerio P, Sommariva M, Stagni EG, Redaelli T, De Carli F, Nobili L. Sleep apnea and periodic leg movements in the first year after spinal cord injury. Sleep Med. 2015 Jan;16(1):59-66. doi: 10.1016/j.sleep.2014.07.019. Epub 2014 Oct 7.

    PMID: 25454844BACKGROUND
  • Foschi M, Rizzo G, Liguori R, Avoni P, Mancinelli L, Lugaresi A, Ferini-Strambi L. Sleep-related disorders and their relationship with MRI findings in multiple sclerosis. Sleep Med. 2019 Apr;56:90-97. doi: 10.1016/j.sleep.2019.01.010. Epub 2019 Jan 21.

    PMID: 30803830BACKGROUND
  • Telles SC, Alves RS, Chadi G. Spinal cord injury as a trigger to develop periodic leg movements during sleep: an evolutionary perspective. Arq Neuropsiquiatr. 2012 Nov;70(11):880-4. doi: 10.1590/s0004-282x2012001100011.

    PMID: 23175202BACKGROUND
  • Levy J, Hartley S, Mauruc-Soubirac E, Leotard A, Lofaso F, Quera-Salva MA, Bensmail D. Spasticity or periodic limb movements? Eur J Phys Rehabil Med. 2018 Oct;54(5):698-704. doi: 10.23736/S1973-9087.17.04886-9. Epub 2017 Dec 4.

    PMID: 29205982BACKGROUND
  • Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 2004 Jul;5(4):385-91. doi: 10.1016/j.sleep.2004.01.012.

    PMID: 15222997BACKGROUND
  • Guilleminault C, Flagg W. Effect of baclofen on sleep-related periodic leg movements. Ann Neurol. 1984 Mar;15(3):234-9. doi: 10.1002/ana.410150304.

    PMID: 6721446BACKGROUND
  • Plante DT. Leg actigraphy to quantify periodic limb movements of sleep: a systematic review and meta-analysis. Sleep Med Rev. 2014 Oct;18(5):425-34. doi: 10.1016/j.smrv.2014.02.004. Epub 2014 Feb 17.

    PMID: 24726711BACKGROUND
  • Kobayashi M, Namba K, Ito E, Nishida S, Nakamura M, Ueki Y, Furudate N, Kagimura T, Usui A, Inoue Y. The validity of the PAM-RL device for evaluating periodic limb movements in sleep and an investigation on night-to-night variability of periodic limb movements during sleep in patients with restless legs syndrome or periodic limb movement disorder using this system. Sleep Med. 2014 Jan;15(1):138-43. doi: 10.1016/j.sleep.2013.08.790. Epub 2013 Oct 31.

    PMID: 24269130BACKGROUND
  • Ferri R, Fulda S, Manconi M, Hogl B, Ehrmann L, Ferini-Strambi L, Zucconi M. Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index. Sleep Med. 2013 Mar;14(3):293-6. doi: 10.1016/j.sleep.2012.08.014. Epub 2012 Oct 12.

    PMID: 23068780BACKGROUND

MeSH Terms

Conditions

Spinal Cord InjuriesNocturnal Myoclonus SyndromeMultiple SclerosisMuscle Spasticity

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersParasomniasDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Marie Christine BLANDIN

    Physiologie, explorations fonctionnelles - Unité des pathologies du sommeil, Hôpital Raymond Poincaré, APHP

    PRINCIPAL INVESTIGATOR
  • Antoine LEOTARD, MD

    Physiologie, explorations fonctionnelles - Unité des pathologies du sommeil, Hôpital Raymond Poincaré, APHP

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2020

First Posted

November 6, 2020

Study Start

February 25, 2021

Primary Completion

July 4, 2024

Study Completion

January 17, 2025

Last Updated

February 11, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations